Translational Program in Cancer Research (CARE)

Scope and aim

Research carried out within CARE focuses on different forms of cancer, with the goal of accelerating the transfer of cutting-edge knowledge and technological progress to the clinic for the prevention, diagnosis and treatment of cancer. Through this program, the quality of cancer research will be enhanced and its impact on clinical practice will be maximised. The scientific and functional aims of CARE include:

  • Promotion of the development and implementation of precision and personalised medicine.
  • Advancement of basic and translational research towards innovation and technology transfer.
  • Establishment of a collaborative and transversal network of clinical, translational and basic researchers.
  • Implementation of an efficient working framework for researchers in order to increase research impact.
  • Facilitation of the use of advanced computational tools in translational research practices.

Structure of the program

Institutions
Core members: IGTP, Germans Trias i Pujol University Hospital, Institut Català d'Oncologia (ICO).
Associate institutions: Josep Carreras Leukaemia Research Institute (IJC), IrsiCaixa, Universitat Autònoma de Barcelona (UAB).

Executive committee
Mireia Margelí, clinical research director
Miguel A Peinado, basic research director
Anna Martínez-Cardús, networking coordinator
Eduard Serra, scientific coordinator
Arola Fortian, training & communications coordinator

CARE Program nodes
Preclinical Models (Coordinator: Meritxell Carrió)
Immunology/Immunotherapy (Coordinators: Esther Ballana, Joan Climent)
Tumour Heterogeneity & Liquid Biopsy (Coordinators: Sofia España, Berta Martín)
Bioinformatics (Coordinators: Sergio Alonso, Bernat Gel)

Pathology-focused multidisciplinary groups
Taskforce for Colorectal Cancer (Coordinators: Eva Martinez-Balibrea, Núria Mulet)
Can Ruti Sarcoma Group (Coordinator: Eduard Serra)

Research groups

2024 highlights

In 2024, CARE completed its consolidation. The different existing nodes unfolded a significant number of activities including regular meetings, technical capsules, etc. The Pathology-Focused Multidisciplinary Groups kept highly operative and new networks were consolidated.

  • 1 Annual scientific meeting
  • 8 Oncology courses and scientific meetings
  • 3 Training capsules
  • 2 Outreach activities
  • 16 CARE translational seminars

2024 Annual Report